3-(2'-spiroadamantane)-4-methoxy-4-(3''-phosphoryloxy)phenyl-1,2-dioxetane: chemiluminescent substrate for alkaline phosphatase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 64599 |
| SCHEMBL ID | 1425353 |
| MeSH ID | M0170587 |
| Synonym |
|---|
| amppd |
| [3-(3'-methoxyspiro[adamantane-2,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate |
| FT-0660583 |
| 122341-56-4 |
| A804879 |
| 3-(4'-methoxyspiro[adamantane-2,3'-[1,2]dioxetan]-4'-yl)phenyl dihydrogen phosphate |
| phenol, 3-(4-methoxyspiro(1,2-dioxetane-3,2'-tricyclo(3.3.1.1(3,7))decan)-4-yl)-, dihydrogen phosphate |
| 3-(2'-spiroadamantane)-4-methoxy-4-(3''-phosphoryloxy)phenyl-1,2-dioxetane |
| ppd-substrate |
| 4-methoxy-4-(3-phosphatephenyl)spiro(1,2-dioxetane)-3,2'-adamantane |
| 3-(4-methoxyspiro(1,2-dioxetane-3,2'-tricyclo(3.3.1.1(3,7))decan)-4-yl)phenyl phosphate |
| AKOS015896576 |
| AKOS025311572 |
| HY-15906 |
| S-7601 |
| S-7600 |
| SCHEMBL1425353 |
| AC-24644 |
| 3-(4'-methoxyspiro[adamantane-2,3'-[1,2]dioxetan]-4'-yl)phenyl dihydrogen |
| mfcd08704558 |
| (3-{3'-methoxyspiro[adamantane-2,2'-[1,4]dioxetan]-3'-yl}phenoxy)phosphonic acid |
| AS-74829 |
| 3-(4-methoxyspiro[1,2-dioxetane-3,2'-tricyclo[3.3.1.1~3,7~]decan]-4-yl)phenyl dihydrogen phosphate |
| DTXSID20924138 |
| BCP07635 |
| 3-(2-spiroadamantane)-4-methoxy-4-(3-phosphoryloxy)phenyl-1,2-dioxetane |
| 3-((1r,3r,5r,7r)-4'-methoxyspiro[adamantane-2,3'-[1,2]dioxetan]-4'-yl)phenyl dihydrogen phosphate |
| lumigen ppd |
| EX-A2648 |
| AM9716 |
| lumi-phos plus |
| phenol, 3-(4-methoxyspiro[1,2-dioxetane-3,2'-tricyclo[3.3.1.13,7]decan]-4-yl)-, 1-(dihydrogen phosphate) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (5.56) | 18.7374 |
| 1990's | 29 (80.56) | 18.2507 |
| 2000's | 2 (5.56) | 29.6817 |
| 2010's | 2 (5.56) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (5.26%) | 6.00% |
| Case Studies | 1 (2.63%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 35 (92.11%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||